Chemodex

Glabridin

CHF 61.00
In stock
CDX-G0194-M0055 mgCHF 61.00
CDX-G0194-M02525 mgCHF 115.00
More Information
Product Details
Synonyms (R)-4-(3,4-Dihydro-8,8-dimethyl-2H,8H-benzo[1,2-b:3,4-b']dipyran-3-yl)-1,3-benzenediol
Product Type Chemical
Properties
Formula

C20H20O4

MW 324.37
CAS 59870-68-7
Source/Host Chemicals Plant
Purity Chemicals ≥98% (HPLC)
Appearance White to light brown powder.
Solubility Soluble in DMSO, ethanol or DMF (all 20mg/ml).
Identity Determined by 1H-NMR.
Declaration Manufactured by Chemodex.
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

InChi Key LBQIJVLKGVZRIW-ZDUSSCGKSA-N
Smiles CC1(C)C=CC2=C(C=CC3=C2OC[C@@H](C4=C(O)C=C(O)C=C4)C3)O1
Shipping and Handling
Shipping AMBIENT
Short Term Storage +20°C
Long Term Storage +20°C
Handling Advice Protect from light and moisture.
Use/Stability Stable for at least 2 years after receipt when stored at RT.
Documents
MSDS Download PDF
Product Specification Sheet
Datasheet Download PDF
Description

Glabridin is a prenylated isoflavonoid found in licorice (Glycyrrhiza glabra L.) root extract that is reported to possess antiviral, antimicrobial, anti-inflammatory, antidiabetic, antiatherogenic, antioxidant, antitumor and estrogen-like properties. These diverse biological activities are largely related to the capacity of glabridin to down-regulate reactive oxygen species, bind to antioxidant effectors and act as a selective estrogen receptor modulator. On a molecular level it is, next to other targets, activating PPARγ, inhibiting JNK1/2 and human carboxylesterase 2 (CES2A). Based on its antioxidant capacity it is also studied as an anti-aging cosmetic agent. Recently, it has been shown in docking experiments to have high binding affinity to the main protease of SARS-CoV-2.

Product References

(1) C. Simmler, et al.; Fitoterapia 90, 160 (2013) | (2) L. Wang, et al.; Acta. Pharmac. Sin. B 5, 310 (2015) | (3) K.J. Lee, et al.; Evid.-Based Compl. Altern. Med. 2015, ID 165457 (2015) | (4) J.F. Rebhun, et al.; Fitoterapia 106, 55 (2015) | (5) C.-T. Chen, et al.; Environ. Toxicol. 33, 679 (2018) | (6) Y.-Q. Song, et al.; Int. J. Biol. Macromol. 137, 261 (2019) | (7) P. Ciganovic, et al.; Antioxidants 8, 445 (2019) | (8) Z.-F. Wang, et al.; Curr. Med. Chem. 27, 1997 (2020) (Review) | (9) R. Islam, et al.; J. Biomol. Struct. Dyn. (Epub ahead of Print) (2020) | (10) B. Goel, et al.; Nat. Prod. Res. (Epub ahead of Print) (2020)

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.